================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
-------------
Date of Report (Date of earliest event reported): June 25, 2004
BOSTON SCIENTIFIC CORPORATION
--------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 1-11083 04-2695240
-------- ------- ----------
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
ONE BOSTON SCIENTIFIC PLACE, NATICK, MASSACHUSETTS 01760-1537
-------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (508) 650-8000
================================================================================
ITEM 5. Other Events and Regulation FD Disclosure
On June 25, 2004, Boston Scientific Corporation publicly issued $600 million
aggregate principal amount of 5.45% senior notes (the "Notes") under its
existing shelf registration statement. The Notes were issued subject to the
terms and conditions set forth in the Underwriting Agreement dated June 22,
2004, as supplemented by the Terms Agreement dated June 22, 2004, among the
Company and the underwriters named therein. In connection with the offering of
the Notes, the Company entered into an Indenture dated as of June 25, 2004, with
JPMorgan Chase Bank, as trustee.
ITEM 7. Financial Statements and Exhibits
Exhibit Number Exhibit Description
-------------- -------------------
1.1 Underwriting Agreement - Basic Provisions, dated June 22, 2004
1.2 Terms Agreement dated June 22, 2004, among Boston Scientific
Corporation and J.P. Morgan Securities Inc., Banc of America
Securities Inc. and Deutsche Bank Securities Inc., as
representatives of the several underwriters named therein.
4.1 Indenture dated as of June 25, 2004, between Boston Scientific
Corporation and JPMorgan Chase Bank (formerly The Chase
Manhattan Bank)
4.2 5.45% Note due June 15, 2014 in the aggregate principal amount
of $500,000,000
4.3 5.45% Note due June 15, 2014 in the aggregate principal amount
of $100,000,000
2
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
BOSTON SCIENTIFIC CORPORATION
Date: June 25, 2004 By: /s/ Larry Knopf
-------------------------------------
Larry Knopf
Vice President, Assistant General
Counsel
3
INDEX TO EXHIBITS
Exhibit Number Exhibit Description
-------------- -------------------
1.1 Underwriting Agreement - Basic Provisions dated June 22, 2004
1.2 Terms Agreement dated June 22, 2004, among Boston Scientific
Corporation and J.P. Morgan Securities Inc., Banc of America
Securities Inc. and Deutsche Bank Securities Inc., as
representatives of the several underwriters named therein
4.1 Indenture dated as of June 25, 2004, between Boston Scientific
Corporation and JPMorgan Chase Bank (formerly The Chase
Manhattan Bank)
4.2 5.45% Note due June 15, 2014 in the aggregate principal amount
of $500,000,000
4.3 5.45% Note due June 15, 2014 in the aggregate principal amount
of $100,000,000
4